Renato Dulbecco and the Impact of Dulbecco’s Modified Eagle’s Medium (DMEM) on Cell Culture

Renato Dulbecco and the Impact of Dulbecco’s Modified Eagle’s Medium (DMEM) on Cell Culture
Renato Dulbecco:   Renato Dulbecco, an Italian-American virologist, was born on February 22, 1914, in Catanzaro, Italy. He passed away on February 19, 2012, in La Jolla, California. In 1975, Dulbecco was awarded the Nobel Prize in Physiology or Medicine for his groundbreaking work on oncoviruses—viruses capable of inducing cancer. His pioneering research has contributed significantly to the fields of cell biology and virology.   One of his key contributions …
more

Growth Media and Differentiation Media in Neuromuscular Labs

Growth Media and Differentiation Media in Neuromuscular Labs
  In neuromuscular research, selecting the appropriate culture media is essential for optimal cell maintenance and functional studies. Two key types of media commonly used are "growth media" and "differentiation media", each serving distinct purposes.   "Growth Media:" Growth media is designed to support the proliferation and maintenance of skeletal muscle cells. It typically consists of:   - Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 (DMEM/F-12) with 2.5 mM L-glutamine and …
more

Immortalized Skeletal Muscle Cells: Advancing DMD Research 

Immortalized Skeletal Muscle Cells: Advancing DMD Research 
    Immortalized Skeletal Muscle Cells: Advancing DMD Research    Immortalized skeletal muscle cells derived from both healthy individuals and Duchenne muscular dystrophy (DMD) patients offer a powerful platform for scientific discovery in the field of neuromuscular disorders. These cells provide a reproducible model for studying disease mechanisms and investigating therapeutic strategies, particularly in the context of exon-skipping therapies.     By using these immortalized cells, researchers can explore how …
more

Cell Scrapers

Cell Scrapers
  Get Acquainted with Essential Scientific Tools and Materials: Cell Scrapers in Research Labs   Cell scrapers are indispensable tools in laboratory cell culture, primarily used for harvesting adherent cells from the surface of culture vessels such as petri dishes, flasks, or multi-well plates. Made from non-toxic, medical-grade plastic, these scrapers feature a flat, rigid blade that allows researchers to gently dislodge cells without damaging them, offering a non-enzymatic alternative …
more

Anti-dystrophin Antibodies and Their Applications in Western Blotting for Quantifying Dystrophin Rescue

Anti-dystrophin Antibodies and Their Applications in Western Blotting for Quantifying Dystrophin Rescue
Dystrophin, a crucial protein for maintaining muscle integrity, is severely deficient in Duchenne Muscular Dystrophy (DMD) patients. Quantifying dystrophin restoration following therapeutic interventions is essential for evaluating treatment efficacy. Western blotting, a widely used protein analysis technique, plays a pivotal role in this quantification, with anti-dystrophin antibodies being central to its success.   Anti-dystrophin antibodies are specifically designed to detect and bind dystrophin protein, making them indispensable for Western blot …
more

Systemic delivery of an AAV9 exonskipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse

Systemic delivery of an AAV9 exonskipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
  Background: Duchenne muscular dystrophy (DMD) is a severe genetic disorder caused by mutations in the DMD gene. These mutations disrupt the dystrophin protein, essential for muscle function. Current treatments, like exon-skipping oligonucleotides, have limitations due to their short lifespan and need for frequent administration.   Objective: This study explored the use of a self-complementary adeno-associated virus (scAAV9) vector expressing U7 small nuclear RNA (snRNA) to target exon 2 of …
more

Increase in Full-Length Dystrophin by Exon Skipping in Duchenne Muscular Dystrophy Patients with Single Exon Duplications: An Open-label Study

Increase in Full-Length Dystrophin by Exon Skipping in Duchenne Muscular Dystrophy Patients with Single Exon Duplications: An Open-label Study
1. Introduction Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder predominantly affecting boys, with an incidence of approximately 1 in 5,000 male births. It is caused by mutations in the DMD gene that lead to disrupted production of dystrophin, a protein essential for muscle stability. Exon skipping is a therapeutic strategy that restores the reading frame of the mutated gene to enable dystrophin production. This study focuses on applying …
more

Challenges of Assessing Exon 53 Skipping of the HumanDMD Transcript with Locked Nucleic Acid-ModifiedAntisense Oligonucleotides in a Mouse Modelfor Duchenne Muscular Dystrophy

Challenges of Assessing Exon 53 Skipping of the HumanDMD Transcript with Locked Nucleic Acid-ModifiedAntisense Oligonucleotides in a Mouse Modelfor Duchenne Muscular Dystrophy
  Duchenne muscular dystrophy (DMD) is a severe genetic disorder caused by mutations in the dystrophin gene, leading to muscle degeneration and early death. Antisense oligonucleotides (AONs) are promising therapeutic agents designed to skip faulty exons in the dystrophin gene and restore functional protein.   This study evaluated the efficiency of AONs targeting exon 53 of the dystrophin gene in a mouse model, using chemically modified AONs to enhance skipping …
more

Rare Diseases and Orphan Diseases

Rare Diseases and Orphan Diseases
  "Rare Diseases" and "Orphan Diseases" are terms often used interchangeably, but they have distinct meanings and implications, particularly in the context of medical research and drug development. Here's an explanation of both, along with their differences:   Rare Diseases - Definition: A rare disease is one that affects a small percentage of the population. The exact threshold for rarity varies by region:   - United States: Affects fewer than …
more

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy

Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy
Antisense oligonucleotides (AONs) have emerged as a promising therapy for Duchenne Muscular Dystrophy (DMD), a severe neuromuscular disease caused by dystrophin deficiency. Early AON drugs like drisapersen and eteplirsen achieved limited success, leading researchers to develop more efficient next-generation AONs. This study focused on refining AONs for exon 51 skipping through advanced chemical modifications and identifying optimal target sites to enhance efficacy and safety.   Researchers screened over 100 AONs …
more

Recent Posts

Categories

I'd be delighted if you could explore the other sections of my website.

Biochemist Researcher . YouTuber . Medical Laboratory Tech

!I am Ali Nik Akhtar

Personal Website​​​​​​​

If you have any questions or would like to discuss further, please feel free to email me. I would be delighted to get to know you better.

Ready to start a collaboration...​​​​​​​

Contact Me

Nikakhtar422@gmail.com

All rights reserved. This website belongs to Ali Nik Akhtar.